ASX - By Stock
|
AVE |
Re:
Ann: December 2023 Quarterly Activities Report & Appendix 4C
|
|
turps
|
8 |
2.3K |
3 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
8
|
2.3K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ann: December 2023 Quarterly Activities Report & Appendix 4C
|
|
turps
|
8 |
2.3K |
3 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
8
|
2.3K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Perrigo
|
|
turps
|
13 |
2.8K |
2 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
13
|
2.8K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Perrigo
|
|
turps
|
13 |
2.8K |
5 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
13
|
2.8K
|
5
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phase III Clinical Trial Investor Webinar
|
|
turps
|
92 |
26K |
3 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
92
|
26K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho raises further $6M for Phase III trial
|
|
turps
|
130 |
27K |
2 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
130
|
27K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho raises further $6M for Phase III trial
|
|
turps
|
130 |
27K |
6 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
130
|
27K
|
6
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho raises further $6M for Phase III trial
|
|
turps
|
130 |
27K |
0 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
130
|
27K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho raises further $6M for Phase III trial
|
|
turps
|
130 |
27K |
1 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
130
|
27K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Trading Halt
|
|
turps
|
21 |
5.7K |
3 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
21
|
5.7K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Trading Halt
|
|
turps
|
21 |
5.7K |
1 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
21
|
5.7K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: June 2023 Quarterly Activities Report & Appendix 4C
|
|
turps
|
31 |
9.5K |
5 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
31
|
9.5K
|
5
|
|
ASX - By Stock
|
AVE |
Re:
Ann: June 2023 Quarterly Activities Report & Appendix 4C
|
|
turps
|
31 |
9.5K |
6 |
21/08/23 |
21/08/23 |
ASX - By Stock
|
31
|
9.5K
|
6
|
|
ASX - By Stock
|
AVE |
Re:
Ann: June 2023 Quarterly Activities Report & Appendix 4C
|
|
turps
|
31 |
9.5K |
0 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
31
|
9.5K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: AVE CBD capsule passes two-year stability milestone
|
|
turps
|
8 |
2.0K |
3 |
22/06/23 |
22/06/23 |
ASX - By Stock
|
8
|
2.0K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ann: AVE adds TPM cannabinoid gummies to portfolio
|
|
turps
|
44 |
10K |
4 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
44
|
10K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: AVE adds TPM cannabinoid gummies to portfolio
|
|
turps
|
44 |
10K |
4 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
44
|
10K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: AVE adds TPM cannabinoid gummies to portfolio
|
|
turps
|
44 |
10K |
4 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
44
|
10K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: AVE adds TPM cannabinoid gummies to portfolio
|
|
turps
|
44 |
10K |
6 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
44
|
10K
|
6
|
|
ASX - By Stock
|
AVE |
Re:
Ann: AVE adds TPM cannabinoid gummies to portfolio
|
|
turps
|
44 |
10K |
3 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
44
|
10K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ann: AVE adds TPM cannabinoid gummies to portfolio
|
|
turps
|
44 |
10K |
4 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
44
|
10K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: March 2023 Quarterly Activities Report & Appendix 4C
|
|
turps
|
8 |
2.3K |
4 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
8
|
2.3K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: March 2023 Quarterly Activities Report & Appendix 4C
|
|
turps
|
8 |
2.3K |
3 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
8
|
2.3K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Chair's Address and CEO Presentation
|
|
turps
|
13 |
2.9K |
5 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
13
|
2.9K
|
5
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho licenses TPM for use in cancer drugs
|
|
turps
|
33 |
8.0K |
1 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
33
|
8.0K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho licenses TPM for use in cancer drugs
|
|
turps
|
33 |
8.0K |
2 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
33
|
8.0K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Change in Substantial Holding
|
|
turps
|
2 |
812 |
3 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
2
|
812
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ann: AVE commences manufacturing for Phase III trial
|
|
turps
|
17 |
3.9K |
5 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
17
|
3.9K
|
5
|
|
ASX - By Stock
|
AVE |
Re:
Ann: AVE commences manufacturing for Phase III trial
|
|
turps
|
17 |
3.9K |
5 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
17
|
3.9K
|
5
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Results of Entitlement Offer
|
|
turps
|
14 |
3.4K |
0 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
14
|
3.4K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Results of Entitlement Offer
|
|
turps
|
14 |
3.4K |
2 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
14
|
3.4K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Results of Entitlement Offer
|
|
turps
|
14 |
3.4K |
1 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
14
|
3.4K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Entitlement Offer to raise $11m for Phase 3 clinical trial
|
|
turps
|
70 |
23K |
2 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
70
|
23K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Entitlement Offer to raise $11m for Phase 3 clinical trial
|
|
turps
|
70 |
23K |
2 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
70
|
23K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Entitlement Offer to raise $11m for Phase 3 clinical trial
|
|
turps
|
70 |
23K |
2 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
70
|
23K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Entitlement Offer to raise $11m for Phase 3 clinical trial
|
|
turps
|
70 |
23K |
0 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
70
|
23K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Entitlement Offer to raise $11m for Phase 3 clinical trial
|
|
turps
|
70 |
23K |
0 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
70
|
23K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Entitlement Offer to raise $11m for Phase 3 clinical trial
|
|
turps
|
70 |
23K |
0 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
70
|
23K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Entitlement Offer to raise $11m for Phase 3 clinical trial
|
|
turps
|
70 |
23K |
0 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
70
|
23K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Entitlement Offer to raise $11m for Phase 3 clinical trial
|
|
turps
|
70 |
23K |
1 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
70
|
23K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Entitlement Offer to raise $11m for Phase 3 clinical trial
|
|
turps
|
70 |
23K |
7 |
12/04/23 |
12/04/23 |
ASX - By Stock
|
70
|
23K
|
7
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho to present at NWR Virtual Healthcare Conference
|
|
turps
|
23 |
6.5K |
4 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
23
|
6.5K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho receives ethics approval for Phase III CBD trial
|
|
turps
|
71 |
21K |
4 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
71
|
21K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Athenex submits Avecho's phytonadione to FDA pre-IND
|
|
turps
|
68 |
15K |
0 |
15/01/23 |
15/01/23 |
ASX - By Stock
|
68
|
15K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Athenex submits Avecho's phytonadione to FDA pre-IND
|
|
turps
|
68 |
15K |
7 |
13/01/23 |
13/01/23 |
ASX - By Stock
|
68
|
15K
|
7
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Athenex submits Avecho's phytonadione to FDA pre-IND
|
|
turps
|
68 |
15K |
4 |
13/01/23 |
13/01/23 |
ASX - By Stock
|
68
|
15K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho receives ethics approval for Phase III CBD trial
|
|
turps
|
71 |
21K |
15 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
71
|
21K
|
15
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho receives ethics approval for Phase III CBD trial
|
|
turps
|
71 |
21K |
9 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
71
|
21K
|
9
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho receives ethics approval for Phase III CBD trial
|
|
turps
|
71 |
21K |
17 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
71
|
21K
|
17
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho receives ethics approval for Phase III CBD trial
|
|
turps
|
71 |
21K |
7 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
71
|
21K
|
7
|
|